Science news

<<  return


Ten years after the publication of recommendations stemming from the 36th Bethesda Conference, the American Heart Association (AHA) and American College of Cardiology (ACC) have updated the guidelines and recommendations establishing eligibility and disqualification criteria for competitive athletes with cardiovascular disease.

Consisting of documents written by 15 task forces and more than 2 years in making, the AHA/ACC scientific statement covers everything from preparticipation screening for cardiovascular disease in competitive athletes to eligibility and disqualification recommendations for athletes with hypertrophic cardiomyopathy, congenital heart disease, valvular heart disease, aortic disease, hypertension, coronary disease, arrhythmias and conduction defects, and channelopathies, among others.

There are also statements from the task force on drugs/performance-enhancing substances and the establishment of emergency action plans involving cardiopulmonary resuscitation  and automated external defibrillators. The new guidelines are published November 2, 2015 in Circulation.